Europe Antacids Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis By Dosage Form (Tablet, Liquid, and Others); Drug Class (Proton Pump Inhibitors, H2 Antagonist, and Acid Neutralizers); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy)

No. of Pages: 148    |    Report Code: TIPRE00021090    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Antacids Market

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentationss

1.3.1        Antacid Market – By Dosage Form

1.3.2        Antacid Market – By Drug Class

1.3.3        Antacid Market – By Distribution Channel

1.3.4        Europe Antacid Market – By Country

2.           Europe Antacid Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Antacid Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Antacid Market- Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Antacid Market - Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Gastrointestinal Diseases

5.1.2        Higher Incidence of Ageing Population

5.2         Market Restraints

5.2.1        Lack of Knowledge Associated with Gastrointestinal Diseases

5.3         Market Opportunities

5.3.1        Increasing Research and Development Activities Regarding Gastric Disorders

5.4         Future Trends

5.4.1        Increasing Growth of the Pharmaceutical Industry

5.5         Impact Analysis

6.           Antacid Market – Europe Analysis

6.1         Europe Antacid Market Revenue Forecasts and Analysis

7.           Europe Antacid Market Analysis and Forecasts to 2027 – By Dosage Form

7.1         Overview

7.2         Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

7.3         Tablet

7.3.1        Overview

7.3.2        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Liquid

7.4.1        Overview

7.4.2        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Others

7.5.1        Overview

7.5.2        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.           Europe Antacid Market Analysis and Forecasts to 2027– By Drug Class

8.1         Overview

8.2         Antacid Market Revenue Share, by Drug Class (2019 and 2027)

8.3         Proton Pump Inhibitors

8.3.1        Overview

8.3.2        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.4         H Antagonist

8.4.1        Overview

8.4.2        H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Acid Neutralizers

8.5.1        Overview

8.5.2        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.3        Magaldrate

8.5.3.1          Overview

8.5.3.2          Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.4        Sucralfate

8.5.4.1          Overview

8.5.4.2          Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

8.5.5        Others

8.5.5.1          Overview

8.5.5.2          Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.           Europe Antacid Market Analysis and Forecasts to 2027– By Distribution Channel

9.1         Overview

9.2         Antacid Market Share, by Distribution Channel, 2019 and 2027, (%)

9.3         Hospital Pharmacy

9.3.1        Overview

9.3.2        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Retail Pharmacy

9.4.1        Overview

9.4.2        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

9.5         Online Pharmacy

9.5.1        Overview

9.5.2        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

10.        Antacid Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1      Europe: Antacid Market

10.1.1     Overview

10.1.2     Europe: Antacid Market, by Country, 2019 & 2027 (%)

10.1.3     Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.1       Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.3.2       Germany: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.3.3       Germany: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.3.3.1       Germany: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.3.4       Germany: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.4     UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.1       UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.4.2       UK: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.4.3       UK: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.4.3.1       UK: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.4.4       UK: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.5     France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.1       France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.5.2       France: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.5.3       France: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.5.3.1       France: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.5.4       France: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.6     Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.1       Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.6.2       Spain: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.6.3       Spain: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.6.3.1       Spain: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.6.4       Spain: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.7     Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Italy: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.7.3       Italy: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.7.3.1       Italy: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.7.4       Italy: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

10.1.8     Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Rest of Europe: Antacid Market, by Dosage Form, 2018–2027 (USD Million)

10.1.8.3       Rest of Europe: Antacid Market, by Drug Class 2018–2027 (USD Million)

10.1.8.3.1       Rest of Europe: Acid Neutralizers Market, by Type 2018–2027 (USD Million)

10.1.8.4       Rest of Europe: Antacid Market, by Distribution Channel, 2018–2027 (USD Million)

11.        Impact Of COVID-19 Pandemic on Europe Antacid Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        COMPANY PROFILES

13.1      Bayer AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Takeda Pharmaceutical Company Limited

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sun Pharmaceutical Industries Ltd

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Sanofi

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Boehringer Ingelheim International GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Dr. Reddy's Laboratories

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Pfizer Inc.

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     roducts and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Reckitt Benckiser Group Plc

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Procter & Gamble

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Germany Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 2.             Germany Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 3.             Germany Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.             UK Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 6.             UK Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 7.             UK Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 8.             UK Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.             France Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 10.          France Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.          France Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 12.          France Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 15.          Spain Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 16.          Spain Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.          Italy Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 18.          Italy Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 19.          Italy Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 20.          Italy Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 21.          Rest of Europe Antacid Market, by Dosage Form – Revenue and Forecast to 2027 (USD Million)

Table 22.          Rest of Europe Antacid Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 23.          Rest of Europe Acid Neutralizers Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 24.          Rest of Europe Antacid Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done By Companies

Table 27.          Glossary of Terms, Antacid Market

LIST OF FIGURES

Figure 1.           Antacid Market Segmentation

Figure 2.           Europe Antacid Market Overview

Figure 3.           Tablet Segment Held Largest Share of Dosage Form in Antacid Market

Figure 4.           Proton Pump Inhibitors Segment Held Largest Share of Drug Class in Antacid Market

Figure 5.           Germany is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Antacid Market - Europe PEST Analysis

Figure 7.           Antacid Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Antacid Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Antacid Market Revenue Share, by Dosage Form (2019 and 2027)

Figure 10.        Tablet: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Liquid: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Antacid Market Revenue Share, by Drug Class (2019 and 2027)

Figure 14.        Proton Pump Inhibitors: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        H Antagonist: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Acid Neutralizers: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Magaldrate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Sucralfate: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Others: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Antacid Market Share, by Distribution Channel, 2019 and 2027 (%)

Figure 21.        Hospital Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Retail Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Online Pharmacy: Antacid Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Europe: Antacid Market, by Key Country – Revenue (2019) (USD Million)

Figure 25.        Europe: Antacid Market, by Country, 2019 & 2027 (%)

Figure 26.        Germany: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        UK: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        France: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Spain: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Italy: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        Rest of Europe: Antacid Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in European Country Markets

Figure 33.        Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Europe Antacids Market

  1. Bayer AG
  2. GlaxoSmithKline plc
  3. Takeda Pharmaceutical Company Limited
  4. Sun Pharmaceutical Industries Ltd
  5. Sanofi
  6. Boehringer Ingelheim International GmbH
  7. Dr. Reddy's Laboratories
  8. Pfizer Inc
  9. Reckitt Benckiser Group Plc
  10. Procter & Gamble